Bladder Cancer
TROP2 Expression Across Molecular Subtypes of Urothelial Carcinoma and Enfortumab Vedotin-resistant Cells.
February 28, 2022
Outcomes by time to definitive chemoradiation treatment for patients with muscle-invasive bladder cancer.
February 28, 2022
Oncologic impact of concomitant prostate cancer characteristics at the time of radical cystoprostatectomy for bladder cancer: a population-based analysis.
February 25, 2022
A clinical study of a CD44v6-targeted fluorescent agent for the detection of non-muscle invasive bladder cancer.
February 25, 2022
Baseline Health-related Quality of Life Predicts Bladder Cancer-specific Survival Following Radical Cystectomy.
February 23, 2022
Dietary fats and their sources in association with the risk of bladder cancer: a pooled analysis of 11 prospective cohort studies.
February 23, 2022
Diagnostic accuracy of vesical imaging-reporting and data system (VI-RADS) for the detection of muscle-invasive bladder cancer: a meta-analysis.
February 22, 2022
Carboplatin-based adjuvant chemotherapy versus observation after radical cystectomy in patients with pN1-3 urothelial bladder cancer.
February 21, 2022
Incidence of bladder cancer in neuro-urological patients in France: a nationwide study.
February 21, 2022
Long term cost comparisons of radical cystectomy versus trimodal therapy for muscle-invasive bladder cancer.
February 18, 2022
Prognostic Impact of CD36 Immunohistochemical Expression in Patients with Muscle-Invasive Bladder Cancer Treated with Cystectomy and Adjuvant Chemotherapy.
February 17, 2022
Associations between Dietary Patterns and Malnutrition, Low Muscle Mass and Sarcopenia in Adults with Cancer: A Scoping Review.
February 17, 2022
A Comprehensive Approach to Clinical Staging of Bladder Cancer.
February 17, 2022